87 related articles for article (PubMed ID: 11275923)
1. Joint effects of C-reactive protein and other risk factors on acute coronary events.
Kervinen H; Palosuo T; Manninen V; Tenkanen L; Vaarala O; Mänttäri M
Am Heart J; 2001 Apr; 141(4):580-5. PubMed ID: 11275923
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effect of persistent Chlamydia pneumoniae infection, autoimmunity, and inflammation on coronary risk.
Huittinen T; Leinonen M; Tenkanen L; Virkkunen H; Mänttäri M; Palosuo T; Manninen V; Saikku P
Circulation; 2003 May; 107(20):2566-70. PubMed ID: 12743003
[TBL] [Abstract][Full Text] [Related]
4. Time-dependent changes of hs-CRP serum concentration in patients with non-ST elevation acute coronary syndrome.
Jahn J; Hellmann I; Maass M; Giannitsis E; Dalhoff K; Katus HA
Herz; 2004 Dec; 29(8):795-801. PubMed ID: 15599677
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein, bezafibrate, and recurrent coronary events in patients with chronic coronary heart disease.
Haim M; Benderly M; Tanne D; Matas Z; Boyko V; Fisman EZ; Tenenbaum A; Zimmlichman R; Battler A; Goldbourt U; Behar S
Am Heart J; 2007 Dec; 154(6):1095-101. PubMed ID: 18035081
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein and prediction of coronary heart disease and global vascular events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER).
Sattar N; Murray HM; McConnachie A; Blauw GJ; Bollen EL; Buckley BM; Cobbe SM; Ford I; Gaw A; Hyland M; Jukema JW; Kamper AM; Macfarlane PW; Murphy MB; Packard CJ; Perry IJ; Stott DJ; Sweeney BJ; Twomey C; Westendorp RG; Shepherd J;
Circulation; 2007 Feb; 115(8):981-9. PubMed ID: 17283264
[TBL] [Abstract][Full Text] [Related]
7. High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: the Third National Health and Nutrition Examination Survey.
Miller M; Zhan M; Havas S
Arch Intern Med; 2005 Oct; 165(18):2063-8. PubMed ID: 16216995
[TBL] [Abstract][Full Text] [Related]
8. Antibody against oxidized low-density lipoprotein predicting myocardial infarction.
Puurunen M; Mänttäri M; Manninen V; Tenkanen L; Alfthan G; Ehnholm C; Vaarala O; Aho K; Palosuo T
Arch Intern Med; 1994 Nov; 154(22):2605-9. PubMed ID: 7979858
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study.
Cushman M; Arnold AM; Psaty BM; Manolio TA; Kuller LH; Burke GL; Polak JF; Tracy RP
Circulation; 2005 Jul; 112(1):25-31. PubMed ID: 15983251
[TBL] [Abstract][Full Text] [Related]
10. Relation of C-reactive protein level and long-term risk of death or myocardial infarction following percutaneous coronary intervention with a sirolimus-eluting stent.
Karha J; Bavry AA; Rajagopal V; Henderson MR; Ellis SG; Brener SJ
Am J Cardiol; 2006 Sep; 98(5):616-8. PubMed ID: 16923447
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein modulates risk prediction based on the Framingham Score: implications for future risk assessment: results from a large cohort study in southern Germany.
Koenig W; Löwel H; Baumert J; Meisinger C
Circulation; 2004 Mar; 109(11):1349-53. PubMed ID: 15023871
[TBL] [Abstract][Full Text] [Related]
12. Elevated C-reactive protein associated with decreased high-density lipoprotein cholesterol in men with spinal cord injury.
Liang H; Mojtahedi MC; Chen D; Braunschweig CL
Arch Phys Med Rehabil; 2008 Jan; 89(1):36-41. PubMed ID: 18164328
[TBL] [Abstract][Full Text] [Related]
13. Serum iron, infection and inflammation; effects on coronary risk.
Kervinen H; Tenkanen L; Palosuo T; Roivainen M; Manninen V; Mänttäri M
Scand Cardiovasc J; 2004 Dec; 38(6):345-8. PubMed ID: 15804800
[TBL] [Abstract][Full Text] [Related]
14. Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial.
Ray KK; Cannon CP; Cairns R; Morrow DA; Rifai N; Kirtane AJ; McCabe CH; Skene AM; Gibson CM; Ridker PM; Braunwald E;
J Am Coll Cardiol; 2005 Oct; 46(8):1417-24. PubMed ID: 16226164
[TBL] [Abstract][Full Text] [Related]
15. High levels of C-reactive protein with low total cholesterol concentrations additively predict all-cause mortality in patients with coronary artery disease.
Jánoskuti L; Förhécz Z; Hosszúfalusi N; Kleiber M; Walentin S; Bálint O; Duba J; Rugonfalvi-Kiss S; Romics L; Karádi I; Füst G; Prohászka Z
Eur J Clin Invest; 2005 Feb; 35(2):104-11. PubMed ID: 15667581
[TBL] [Abstract][Full Text] [Related]
16. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
[TBL] [Abstract][Full Text] [Related]
17. Does high-sensitivity C-reactive protein add prognostic value to the TIMI-Risk Score in individuals with non-ST elevation acute coronary syndromes?
Correia LC; Lima JC; Rocha MS; D'Oliveira Junior A; Péricles Esteves J
Clin Chim Acta; 2007 Jan; 375(1-2):124-8. PubMed ID: 16916502
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of preintervention C-reactive protein on clinical outcome after directional coronary atherectomy followed by stent implantation.
Niccoli G; Ferrante G; Mongiardo R; Perfetti M; Belloni F; Burzotta F; Porto I; Leone AM; Rebuzzi AG; Crea F
Cardiovasc Revasc Med; 2007; 8(3):156-60. PubMed ID: 17765643
[TBL] [Abstract][Full Text] [Related]
19. The value of C-reactive protein in cardiovascular risk prediction: the Rotterdam Study.
van der Meer IM; de Maat MP; Kiliaan AJ; van der Kuip DA; Hofman A; Witteman JC
Arch Intern Med; 2003 Jun; 163(11):1323-8. PubMed ID: 12796068
[TBL] [Abstract][Full Text] [Related]
20. hsCRP and HDL effects of statins trial (CHEST): rapid effect of statin therapy on C-reactive protein and high-density lipoprotein levels A clinical investigation.
Ansell BJ; Watson KE; Weiss RE; Fonarow GC
Heart Dis; 2003; 5(1):2-7. PubMed ID: 12549983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
